556 filings
Page 6 of 28
SC 13G/A
STAB
Statera Biopharma, Inc.
11 Feb 21
CLEVELAND BIOLABS / HARPEL JAMES W ownership change
1:42pm
425
STAB
Statera Biopharma, Inc.
8 Jan 21
Business combination disclosure
5:22pm
8-K
STAB
Statera Biopharma, Inc.
8 Jan 21
Regulation FD Disclosure
5:22pm
8-K
STAB
Statera Biopharma, Inc.
21 Dec 20
Submission of Matters to a Vote of Security Holders
4:05pm
10-Q
2020 Q3
STAB
Statera Biopharma, Inc.
Quarterly report
16 Nov 20
8:00am
DEFA14A
STAB
Statera Biopharma, Inc.
6 Nov 20
Additional proxy soliciting materials
5:00pm
DEF 14A
STAB
Statera Biopharma, Inc.
Definitive proxy
6 Nov 20
5:00pm
8-K
STAB
Statera Biopharma, Inc.
28 Oct 20
Other Events
5:24pm
425
STAB
Statera Biopharma, Inc.
28 Oct 20
Business combination disclosure
5:22pm
8-K
STAB
Statera Biopharma, Inc.
21 Oct 20
Cytocom, Inc. Issues Shareholder Letter
4:10pm
425
STAB
Statera Biopharma, Inc.
21 Oct 20
Business combination disclosure
4:08pm
8-K
STAB
Statera Biopharma, Inc.
19 Oct 20
Cytocom and Cleveland BioLabs Announce Definitive Merger Agreement
4:15pm
425
STAB
Statera Biopharma, Inc.
19 Oct 20
Business combination disclosure
4:13pm
8-K
STAB
Statera Biopharma, Inc.
13 Oct 20
Departure of Directors or Certain Officers
8:30am
8-K
STAB
Statera Biopharma, Inc.
24 Aug 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:46am
8-K
STAB
Statera Biopharma, Inc.
14 Aug 20
Departure of Directors or Certain Officers
8:45am
10-Q
2020 Q2
STAB
Statera Biopharma, Inc.
Quarterly report
14 Aug 20
8:30am
8-K
STAB
Statera Biopharma, Inc.
31 Jul 20
Entry into a Material Definitive Agreement
5:15pm
SC 13G
Armistice Capital, LLC
11 Jun 20
CLEVELAND BIOLABS / ARMISTICE CAPITAL ownership change
4:49pm
D
STAB
Statera Biopharma, Inc.
4 Jun 20
$1.59M in equity / options / securities to be acquired, sold $1.59M, 3 investors
5:15pm